Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today we highlight:
- a blog post reporting how the New Civil Liberties Alliance filed a reply brief at the Supreme Court on behalf of Judge Newman;
- a blog post highlighting how “a unanimous court rejected the idea that a generics pharmaceutical manufacturer . . . can be held responsible for infringements of patents held by the branded manufacturer . . . based on the decisions of doctors and pharmacies to use the generic compound for patented uses of the drug”;
- a blog post explaining how, when “[c]onfronted with four patents drawn to the same basic invention, the Federal Circuit held one group of claims ineligible and a second group eligible”; and
- a blog post discussing how “more than a dozen patent matters now sit before the [Supreme] Court.”
